Product Information
QUETIAPINE ER 300 MG TABLET is a generic product labeled by ScieGen Pharmaceuticals Inc., priced at $0.2764 per EA under NDC 50228038360. Its NADAC has been published 359 times since Oct 9, 2019.
FDA first approved this application on Nov 29, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 mg/1
Manufacturer
ScieGen Pharmaceuticals Inc.NDC
50228038360
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
QUETIAPINE FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA209635FDA Approved
11/29/2017
TE Code
AB
On Market Since
11/29/2017
Pharmacological Classes
Price Statistics
The NADAC for QUETIAPINE ER 300 MG TABLET has been published 359 times since Oct 9, 2019, and over the history we have for it it has declined 40.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2764 per EA |
|---|---|
| All-time high | $0.6037 (May 13, 2020) |
| All-time low | $0.1954 (Nov 20, 2024) |
| 52-week high | $0.2805 |
| 52-week low | $0.2559 |
| Median price | $0.3306 |
| Average price | $0.3473 |
| Largest weekly change | +47.7% (Aug 21, 2024) |
| Weeks tracked | 359 |
| Tracking since | Oct 9, 2019 |
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 54% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of QUETIAPINE ER 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for QUETIAPINE ER 300 MG TABLET, manufactured by ScieGen Pharmaceuticals Inc., is $0.2764 per EA (NDC 50228038360), effective Aug 19, 2026.
How has the price of QUETIAPINE ER 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for QUETIAPINE ER 300 MG TABLET has declined 40.5%. It has been tracked across 359 weekly CMS publications since Oct 9, 2019.
What are the highest and lowest recorded NADAC prices for QUETIAPINE ER 300 MG TABLET?
Since Oct 9, 2019, the NADAC for QUETIAPINE ER 300 MG TABLET has ranged from a low of $0.1954 (Nov 20, 2024) to a high of $0.6037 (May 13, 2020), with a median of $0.3306 per EA.
Are there cheaper alternatives to QUETIAPINE ER 300 MG TABLET?
Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, QUETIAPINE FUMARATE 300 MG TAB, is $0.1285 per EA — about 54% below QUETIAPINE ER 300 MG TABLET.
Who manufactures QUETIAPINE ER 300 MG TABLET?
QUETIAPINE ER 300 MG TABLET (NDC 50228038360) is labeled by ScieGen Pharmaceuticals Inc., and CMS classifies it as a generic product.